Skip to main content Deutsch

Mikulits Lab

Wolfgang Mikulits, Ao.Univ.-Prof. Mag. Dr.

Coordinator of Research Focus
"Tumor Progression and Metastasis"
Group Leader

T: +43 (0)1 40160-57527
F: +43 (0)1 40160-957519
wolfgang.mikulits@meduniwien.ac.at

ORCID: 0000-0003-4612-7106

Research Focus

The spread of cells from the primary cancer to distant organs - denoted as metastasis - is the most fearsome aspect of cancer. The metastatic process has exceptional clinical relevance and represents the major reason for the death of cancer patients.

We focus on highly aggressive liver cancers and the molecular mechanisms responsible for driving progression the disease. Changes in cancer cell plasticity by epithelial to mesenchymal transition are of particular interest for local cell invasion, immune cell interactions in the tumor microenvironment and drug resistance.

Legend: Study the role of AXL and TGF-β signaling in cancer cell invasion, immune surveillance and drug resistance of liver cancer.

In particular, we aim at understanding the role of the receptor tyrosine kinase AXL and TGF-β signaling in these processes as both are crucially involved in regulating cancer cell functions and the composition of the tumor microenvironment by their molecular collaboration.

Hypothesis-driven models translated into pre-clinical and clinical settings are used to identify and functionally characterize novel targets amenable to diagnostic/prognostic assessment and therapeutic intervention of liver cancer.

Selected Publications

Intrinsic and Extrinsic Control of Hepatocellular Carcinoma by TAM Receptors.
Hedrich V, Breitenecker K, Djerlek L, Ortmayr G, Mikulits W.
Cancers. 2021 Oct 29;13(21):5448. doi: 10.3390/cancers13215448.

Transforming Growth Factor-β and Axl Induce CXCL5 and Neutrophil Recruitment in Hepatocellular Carcinoma.
Haider C, Hnat J, Wagner R, Huber H, Timelthaler G, Grubinger M, Coulouarn C, Schreiner W, Schlangen K, Sieghart W, Peck-Radosavljevic M, Mikulits W.
Hepatology. 2019 Jan;69(1):222-236. doi: 10.1002/hep.30166

Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis.
Dengler M, Staufer K, Huber H, Stauber R, Bantel H, Weiss KH, Starlinger P, Pock H, Klöters-Plachky P, Gotthardt DN, Rauch P, Lackner C, Stift J, Brostjan C, Gruenberger T, Kumada T, Toyoda H, Tada T, Weiss TS, Trauner M, Mikulits W.
Oncotarget. 2017 Jul 11;8(28):46234-46248. doi: 10.18632/oncotarget.17598

The PDGFRα-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma.
Govaere O, Petz M, Wouters J, Vandewynckel YP, Scott EJ, Topal B, Nevens F, Verslype C, Anstee QM, Van Vlierberghe H, Mikulits W, Roskams T.
Oncogene. 2017 Nov 23;36(47):6605-6616. doi: 10.1038/onc.2017.260.

Role of epithelial to mesenchymal transition in hepatocellular carcinoma.
Giannelli G, Koudelkova P, Dituri F, Mikulits W.
J Hepatol. 2016 Oct;65(4):798-808. doi: 10.1016/j.jhep.2016.05.007

Axl activates autocrine transforming growth factor-β signaling in hepatocellular carcinoma.
Reichl P, Dengler M, van Zijl F, Huber H, Führlinger G, Reichel C, Sieghart W, Peck-Radosavljevic M, Grubinger M, Mikulits W.
Hepatology. 2015 Mar;61(3):930-41. doi: 10.1002/hep.27492

PDGF enhances IRES-mediated translation of Laminin B1 by cytoplasmic accumulation of La during epithelial to mesenchymal transition.
Petz M, Them NC, Huber H, Mikulits W.
Nucleic Acids Res. 2012 Oct;40(19):9738-49. doi: 10.1093/nar/gks760.

All Publications

PubmedDatabase

Vorstellung Wolfgang Mikulits, Michael Grusch

Play

Financial Support